Global Typhoid Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 02-Feb-2023
No. of pages: 119

The report focuses on the Typhoid Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Typhoid Vaccine market.

Major Players in the Typhoid Vaccine market are:

Sanofi

Pfizer, Inc.

AstraZeneca

GlaxoSmithKline plc

Merck & Co. Inc.

Johnson & Johnson.

On the basis of types, the Typhoid Vaccine market is primarily split into:

Ty21a

Vi capsular polysaccharide vaccine

Vi Conjugate (Vi-TT)

Vi Conjugate (Vi-REPA).

On the basis of applications, the market covers:

Hospitals

Pharmacies

Clinics / Health Care Centers

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Typhoid Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Typhoid Vaccine Market Overview
1.1 Product Overview and Scope of Typhoid Vaccine Market
1.2 Typhoid Vaccine Market Segment by Type
1.2.1 Global Typhoid Vaccine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Typhoid Vaccine Market Segment by Application
1.3.1 Typhoid Vaccine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Typhoid Vaccine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Typhoid Vaccine (2017-2029)
1.5.1 Global Typhoid Vaccine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Typhoid Vaccine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Typhoid Vaccine Industry
1.7 Impact of Carbon Neutrality on the Typhoid Vaccine Industry

2 Typhoid Vaccine Market Upstream and Downstream Analysis
2.1 Typhoid Vaccine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Typhoid Vaccine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Sanofi
3.1.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Typhoid Vaccine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Pfizer, Inc.
3.2.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Typhoid Vaccine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 AstraZeneca
3.3.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Typhoid Vaccine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 GlaxoSmithKline plc
3.4.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Typhoid Vaccine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Merck & Co. Inc.
3.5.1 Merck & Co. Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Typhoid Vaccine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Johnson & Johnson.
3.6.1 Johnson & Johnson. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Typhoid Vaccine Market Performance (2017-2022)
3.6.4 Business Overview

4 Global Typhoid Vaccine Market Landscape by Player
4.1 Global Typhoid Vaccine Sales and Share by Player (2017-2022)
4.2 Global Typhoid Vaccine Revenue and Market Share by Player (2017-2022)
4.3 Global Typhoid Vaccine Average Price by Player (2017-2022)
4.4 Global Typhoid Vaccine Gross Margin by Player (2017-2022)
4.5 Typhoid Vaccine Market Competitive Situation and Trends
4.5.1 Typhoid Vaccine Market Concentration Rate
4.5.2 Typhoid Vaccine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Typhoid Vaccine Sales, Revenue, Price Trend by Type
5.1 Global Typhoid Vaccine Sales and Market Share by Type (2017-2022)
5.2 Global Typhoid Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global Typhoid Vaccine Price by Type (2017-2022)
5.4 Global Typhoid Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Typhoid Vaccine Sales, Revenue and Growth Rate of Ty21a (2017-2022)
5.4.2 Global Typhoid Vaccine Sales, Revenue and Growth Rate of Vi capsular polysaccharide vaccine (2017-2022)
5.4.3 Global Typhoid Vaccine Sales, Revenue and Growth Rate of Vi Conjugate (Vi-TT) (2017-2022)
5.4.4 Global Typhoid Vaccine Sales, Revenue and Growth Rate of Vi Conjugate (Vi-REPA). (2017-2022)

6 Global Typhoid Vaccine Market Analysis by Application
6.1 Global Typhoid Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global Typhoid Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Typhoid Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Typhoid Vaccine Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Typhoid Vaccine Consumption and Growth Rate of Pharmacies (2017-2022)
6.3.3 Global Typhoid Vaccine Consumption and Growth Rate of Clinics / Health Care Centers (2017-2022)

7 Global Typhoid Vaccine Sales and Revenue Region Wise (2017-2022)
7.1 Global Typhoid Vaccine Sales and Market Share, Region Wise (2017-2022)
7.2 Global Typhoid Vaccine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Typhoid Vaccine Market Forecast (2022-2029)
8.1 Global Typhoid Vaccine Sales, Revenue Forecast (2022-2029)
8.1.1 Global Typhoid Vaccine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Typhoid Vaccine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Typhoid Vaccine Price and Trend Forecast (2022-2029)
8.2 Global Typhoid Vaccine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.2.3 China Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.2.5 India Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Typhoid Vaccine Sales and Revenue Forecast (2022-2029)
8.3 Global Typhoid Vaccine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Typhoid Vaccine Revenue and Growth Rate of Ty21a (2022-2029)
8.3.2 Global Typhoid Vaccine Revenue and Growth Rate of Vi capsular polysaccharide vaccine (2022-2029)
8.3.3 Global Typhoid Vaccine Revenue and Growth Rate of Vi Conjugate (Vi-TT) (2022-2029)
8.3.4 Global Typhoid Vaccine Revenue and Growth Rate of Vi Conjugate (Vi-REPA). (2022-2029)
8.4 Global Typhoid Vaccine Consumption Forecast by Application (2022-2029)
8.4.1 Global Typhoid Vaccine Consumption Value and Growth Rate of Hospitals (2022-2029)
8.4.2 Global Typhoid Vaccine Consumption Value and Growth Rate of Pharmacies (2022-2029)
8.4.3 Global Typhoid Vaccine Consumption Value and Growth Rate of Clinics / Health Care Centers (2022-2029)
8.5 Typhoid Vaccine Market Forecast Under COVID-19

9 Industry Outlook
9.1 Typhoid Vaccine Market Drivers Analysis
9.2 Typhoid Vaccine Market Restraints and Challenges
9.3 Typhoid Vaccine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Typhoid Vaccine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Typhoid Vaccine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Typhoid Vaccine Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs